RE:RE:RE:Ever get the feeling that:I agree; it does seem like a stretch. I was thinking about AN today; they list as partners Roche, MSD aka Merck and ONC. Let us assume AN is not out of it. Merck and Pfizer are together on BRACELET-1. Roche has the stellar GOBLET.
Let us imagine that Roche, & Pfizer/Merck get together and take an offer to ONC. The threesome would be an entity, and they could do more for patients as an entity. Specializing in their own areas of expertise but as a cohesive unit. if you will. Then there is AN to consider, and I am assuming they are still in, are currently in trials with Roche and MSD, and still wanting to continue the partnership with ONC I am betting.
The above is idle speculation, and perhaps they will do it the old fashioned way and bid.
Regardless of how it comes, if it comes, shareholders will be in a good seat.
Cheers